Page last updated: 2024-11-02

phenoxybenzamine and Fetal Growth Restriction

phenoxybenzamine has been researched along with Fetal Growth Restriction in 1 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Research Excerpts

ExcerptRelevanceReference
"To determine whether the reduction in maternal placental blood flow associated with malnutrition during pregnancy results from alpha-adrenergic vasoconstriction, we measured cardiac output, uteroplacental blood flow and uteroplacental vascular resistance in ad libitum-fed and in 50% diet-restricted term-pregnant rats, using radioactive-labeled microspheres before, and again after, alpha-adrenergic receptor blockade with phenoxybenzamine."3.67Catecholamine-mediated reduction in uteroplacental blood flow in the diet-restricted, term-pregnant rat. ( Ahokas, RA; Anderson, GD; Lipshitz, J; Reynolds, SL, 1986)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahokas, RA1
Reynolds, SL1
Anderson, GD1
Lipshitz, J1

Other Studies

1 other study available for phenoxybenzamine and Fetal Growth Restriction

ArticleYear
Catecholamine-mediated reduction in uteroplacental blood flow in the diet-restricted, term-pregnant rat.
    The Journal of nutrition, 1986, Volume: 116, Issue:3

    Topics: Animals; Birth Weight; Blood Pressure; Body Weight; Cardiac Output; Deficiency Diseases; Diet; Femal

1986